Surmodics Investor Relations Material
Latest events
Q2 2024
Surmodics
Q2 2025
30 Apr, 2025
Q1 2025
30 Jan, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Surmodics Inc
Access all reports
Surmodics Inc. is a provider of medical device and in vitro diagnostic technologies. The company develops surface modification coatings, drug delivery technologies, and diagnostic components. Its products are used by medical device manufacturers and diagnostic test developers, particularly in cardiovascular and peripheral vascular applications. Surmodics also offers contract research and development services. The company is headquartered in Eden Prairie, Minnesota, and its shares are listed on the NASDAQ.
Latest articles
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
Ticker symbol
SRDX
Country
🇺🇸 United States